ARHGDIA (GDIA1 or NPHS8) Antibody - Western Blot Validated

Biological Background

When control selection matters, this antibody helps you explore ARHGDIA in a structured study. ARHGDIA is a scaffold that can coordinate signaling with cytoskeletal remodeling. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol GDIA1.

Use in the Laboratory

Comparative analysis across confluence states can reveal junctional coupling or stress-fiber reorganization. Time course design can be decisive when regulation is transient or compartment dependent. Kidney disease modeling efforts may include this target when exploring podocyte stress responses and structural change.

Interpreting changes can benefit from separating expression differences from redistribution, particularly when the target cycles between compartments.

To keep datasets interpretable, labs often document:

• differences across cell density or substrate stiffness
• association with junctional complexes or focal adhesions
• remodeling after perturbation of polymerization or contractility

Version Notes

This denaturing-format version is geared toward targets presented after reduction and denaturation, where epitope exposure can shift from native conformations. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Predefine decision rules for excluding outliers so analysis remains transparent.

For challenging targets, pairing ARHGDIA measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Integrate the denaturing-format version into your design so ARHGDIA signals can be interpreted alongside matched controls.